| Immunology of COVID-19: current state of the science N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ... Immunity 52 (6), 910-941, 2020 | 1812 | 2020 |
| Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis K Fischer, HH Ruiz, K Jhun, B Finan, DJ Oberlin, V Van Der Heide, ... Nature medicine 23 (5), 623-630, 2017 | 321 | 2017 |
| Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19 I Kusmartseva, W Wu, F Syed, V Van Der Heide, M Jorgensen, P Joseph, ... Cell metabolism 32 (6), 1041-1051. e6, 2020 | 174 | 2020 |
| MicroRNA‐146a controls Th1‐cell differentiation of human CD4+ T lymphocytes by targeting PRKCε P Möhnle, SV Schütz, V van der Heide, M Hübner, B Luchting, ... European journal of immunology 45 (1), 260-272, 2015 | 70 | 2015 |
| Advancing scientific knowledge in times of pandemics N Vabret, R Samstein, N Fernandez, M Merad, ... Nature Reviews Immunology 20 (6), 338-338, 2020 | 54 | 2020 |
| Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children ND Beckmann, PH Comella, E Cheng, L Lepow, AG Beckmann, SR Tyler, ... Nature communications 12 (1), 4854, 2021 | 52 | 2021 |
| Limited extent and consequences of pancreatic SARS-CoV-2 infection V van der Heide, S Jangra, P Cohen, R Rathnasinghe, S Aslam, T Aydillo, ... Cell Reports 38 (11), 2022 | 49 | 2022 |
| Down-regulation of MicroRNA-31 in CD4+ T Cells Contributes to Immunosuppression in Human Sepsis by Promoting TH2 Skewing V van der Heide, P Möhnle, J Rink, J Briegel, S Kreth Anesthesiology 124 (4), 908-922, 2016 | 44 | 2016 |
| Chemokine signatures of pathogen-specific T cells I: Effector T cells J Eberlein, B Davenport, TT Nguyen, F Victorino, K Jhun, V van der Heide, ... The Journal of Immunology 205 (8), 2169-2187, 2020 | 35 | 2020 |
| Neutralizing antibody response in mild COVID-19 V van der Heide Nature Reviews Immunology 20 (6), 352-352, 2020 | 33 | 2020 |
| Sampling the host response to SARS-CoV-2 in hospitals under siege AW Charney, NW Simons, K Mouskas, L Lepow, E Cheng, J Le Berichel, ... Nature Medicine 26 (8), 1157-1158, 2020 | 30 | 2020 |
| Aging of antiviral CD8+ memory T cells fosters increased survival, metabolic adaptations, and lymphoid tissue homing B Davenport, J Eberlein, V van der Heide, K Jhun, TT Nguyen, F Victorino, ... The Journal of Immunology 202 (2), 460-475, 2019 | 19 | 2019 |
| Advancing beyond the twists and turns of T cell exhaustion in cancer V van der Heide, E Humblin, A Vaidya, AO Kamphorst Science translational medicine 14 (670), eabo4997, 2022 | 17 | 2022 |
| CD28 days later: Resurrecting costimulation for CD8+ memory T cells V van der Heide, D Homann European journal of immunology 46 (7), 1587-1591, 2016 | 17 | 2016 |
| SARS-CoV-2 cross-reactivity in healthy donors V van Der Heide Nature Reviews Immunology 20 (7), 408-408, 2020 | 16 | 2020 |
| Chemokine signatures of pathogen-specific T cells II: Memory T cells in acute and chronic infection B Davenport, J Eberlein, TT Nguyen, F Victorino, V van der Heide, ... The Journal of Immunology 205 (8), 2188-2206, 2020 | 8 | 2020 |
| Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1+ PD-1+ CD8 T cells E Humblin, I Korpas, J Lu, D Filipescu, V van der Heide, S Goldstein, ... Science immunology 8 (86), eadg0878, 2023 | 6 | 2023 |
| Shared CD8+ T cell receptors for SARS-CoV-2 R Levantovsky, V van Der Heide Nature Reviews Immunology 20 (10), 591-591, 2020 | 5 | 2020 |
| Chronic granulomatous disease in an adult recognized by an invasive aspergillosis I Kaufmann, J Briegel, V van der Heide, A Chouker, L Frey, ... The American journal of the medical sciences 343 (2), 174-176, 2012 | 5 | 2012 |
| Lentiviral-vector-based dendritic cell vaccine synergizes with checkpoint blockade to clear chronic viral infection TD Norton, T Tada, R Leibowitz, V van der Heide, D Homann, NR Landau Molecular Therapy 28 (8), 1795-1805, 2020 | 4 | 2020 |
